Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Lupin Gains FDA Approval for Generic Colonoscopy Prep Drug with 180-Day First-to-File Exclusivity
Lupin secures FDA ANDA approval for a generic colonoscopy prep drug, earning 180-day first-to-file exclusivity in the U.S. generics market.
Pharma Now Editorial Team
AstraZeneca Gains FDA Approval for Imfinzi Combination Regimen in Bladder Cancer
AstraZeneca's Imfinzi combination wins FDA approval in bladder cancer, backed by a 60.7-month efficacy dataset with GMP and process validation implications.
Pharma Now Editorial Team
Merck Gains FDA Breakthrough Therapy Designation for Calderasib in KRAS G12C Lung Cancer
Merck's calderasib receives FDA Breakthrough Therapy designation in KRAS G12C lung cancer, accelerating CMC and manufacturing readiness timelines.
Pharma Now Editorial Team
AstraZeneca Reports Mixed Phase III Results for Anselamimab in Cardiac AL Amyloidosis Trial
AstraZeneca's Phase III anselamimab trial in cardiac AL amyloidosis returns mixed results, raising manufacturing and regulatory contingency questions.
Pharma Now Editorial Team
